GPD-1116 is an orally active inhibitor of phosphodiesterase (PDE)4 and PDE1. The compound effectively reduces smoke-induced apoptosis in lung cells. Additionally, GPD-1116 has shown efficacy in various animal disease models, including emphysema, acute lung injury, chronic obstructive pulmonary disease (COPD), asthma, and pulmonary arterial hypertension.
Molecular Weight:
352.39
CAS Number:
[690690-72-3]
Formula:
C22H16N4O
Target:
Apoptosis
T201696
* VAT and and shipping costs not included. Errors and price changes excepted
